European Institute of Oncology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:European Institute of Oncology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9377
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic tumors, ovarian tumors, prostate tumors, urological tumors, stomach tumors, bowel tumors, and others. It also provides treatment for head and neck tumors, pancreatic tumors, neuroendocrine tumors, skin tumors and melanoma, among others. IEO provides educational services such as PhD programs and post doctoral program. The institute offers research services including basic, translational and clinical research. It also provides clinical services such as clinical dietary regime and nutrition, physiotherapy for rehabilitation after surgery, speech therapy, oral care, and radiotherapy. IEO is headquartered in Milano, Italy.

European Institute of Oncology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
European Institute of Oncology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
European Institute of Oncology, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
European Institute of Oncology Enters into Agreement with Rasna Therapeutics 10
European Institute of Oncology Enters Into Co-Development Agreement With Sigma Tau Industrie 11
European Institute of Oncology Enters Into Agreement With Nerviano Medical Sciences For Anti-Cancer Drugs 12
Licensing Agreements 13
European Institute of Oncology Enters Into Licensing Agreement With University of Pisa 13
European Institute of Oncology – Key Competitors 14
European Institute of Oncology – Key Employees 15
European Institute of Oncology – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Dec 21, 2017: Substantial EU Funding to International BOUNCE Consortium 17
Other Significant Developments 18
Mar 05, 2018: Novel App Designed to Facilitate Biomarker-Driven Trials of Targeted Anti-Cancer Agents 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
European Institute of Oncology, Pharmaceuticals & Healthcare, Key Facts 2
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
European Institute of Oncology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
European Institute of Oncology, Deals By Therapy Area, 2012 to YTD 2018 8
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
European Institute of Oncology Enters into Agreement with Rasna Therapeutics 10
European Institute of Oncology Enters Into Co-Development Agreement With Sigma Tau Industrie 11
European Institute of Oncology Enters Into Agreement With Nerviano Medical Sciences For Anti-Cancer Drugs 12
European Institute of Oncology Enters Into Licensing Agreement With University of Pisa 13
European Institute of Oncology, Key Competitors 14
European Institute of Oncology, Key Employees 15
European Institute of Oncology, Other Locations 16

List of Figures
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
European Institute of Oncology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[European Institute of Oncology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Havells India Ltd (HAVELLS):企業の財務・戦略的SWOT分析
    Havells India Ltd (HAVELLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Milestone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Milestone Pharmaceuticals Inc (Milestone Pharmaceuticals) is a cardiovascular drug development company that develops novel small molecule therapeutics. The company undertakes the development of small molecule therapeutics based on clinically validated mechanisms, for the treatment of cardiov …
  • Genomic Health Inc (GHDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kyocera Corporation (6971):企業の財務・戦略的SWOT分析
    Kyocera Corporation (6971) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Volga Gas plc (VGAS):企業の財務・戦略的SWOT分析
    Summary Volga Gas Plc (Volga Gas) is an oil and gas company that provides oil and gas exploration and production services. The company acquires, produces and develops oil, natural gas deposit properties, and others. It owns and operates oil and gas producing assets in Karpenskiy licence area, Pre-Ca …
  • Sabre Corporation:企業の戦略・SWOT・財務情報
    Sabre Corporation - Strategy, SWOT and Corporate Finance Report Summary Sabre Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pinnacle West Capital Corporation (PNW):企業の財務・戦略的SWOT分析
    Pinnacle West Capital Corporation (PNW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Phatra Leasing Public Company Ltd (PL):企業の財務・戦略的SWOT分析
    Phatra Leasing Public Company Ltd (PL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ArcDia International Oy Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ArcDia International Oy Ltd (ArcDia International) is a healthcare service provider that offers vitro diagnostic services and develops products for the rapid testing of infectious diseases. The company's products include maripoc test system, an automated system for rapid multianalyte identif …
  • Finisar Corp (FNSR):企業の財務・戦略的SWOT分析
    Summary Finisar Corp (Finisar), a subsidiary of II-VI Inc, is a technology company that offers optical communication products. The company offers products such as optical transceivers, optical cables, optical engines, optical components, optical instrumentation, ROADMs, and optical amplifiers. It of …
  • Cadent Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Cadent Therapeutics (Cadent), formerly Luc Therapeutics Inc, is a precision neuroscience company that offers medicines for serious neurological diseases. The company's products comprise NR2B positive allosteric modulators, NR2A negative allosteric modulators and NR2B negative allosteric modu …
  • ACWA Power International:企業の戦略的SWOT分析
    ACWA Power International - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Edmond de Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務情報
    Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PTT Public Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    PTT Public Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary PTT Public Co Ltd (PTT) is a state-owned integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carr …
  • Sunkist Growers Inc:企業の戦略的SWOT分析
    Sunkist Growers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Mazda Motor Corp (7261):企業の財務・戦略的SWOT分析
    Mazda Motor Corp (7261) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆